大葉大學圖書館 |

Venture capital and the European biotechnology industry[electronicresource] /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
杜威分類號:	660.6068/1
書名/作者:	Venture capital and the European biotechnology industry/ William Bains.
作者:	Bains, William,
出版者:	Basingstoke [England] ; : Palgrave Macmillan,, 2009.
面頁冊數:	1 online resource (viii, 220 p.) : : ill.
附註:	Description based on print version record.
標題:	Biotechnology industries - Finance. - Europe
標題:	Venture capital.
ISBN:	9780230227262 (electronic bk.)
ISBN:	0230227260 (electronic bk.)
書目註:	Includes bibliographical references (p. 201-215) and indexes.
內容註:	Introduction : the facts -- The biotechnology industry and venture capital -- Europe falls behind -- Why does Europe do so poorly? Some inadequate explanations -- Under-investment in European biotechnology -- Public markets and under-investment -- VC management of companies -- VC effects on business efficacy -- Investor blockade of business -- Pomp and circumstances -- The real VC business model -- What to do about it: government -- What to do about it: business -- References -- Index.
摘要、提要註:	Why do so many European biotechnology companies fail? This book finds an answer in the behavior of the investors who dominate the industry and control the behavior of the companies they invest in. Starting froma detailed analysis of the history of the industry from its earliest days, this book cuts through the hype and mythology to identify what really happened to the biotechnology industryin Europe, what went wrong with the business, the management and the investment, and who are the controlling figures that made it happen. Bains uses real case studies anda wealth of statistical data to show how systematic under-investment and extraordinary business decisions have made European companies stunted mimics of their US counterparts. Building on an inside knowledge of how venture capital really works, he shows how this is not an accidentalside-product of European inexperience or lack of business acumen, but a necessary result of how venture capitalists run their businesses in Europe. This is an essential book for entrepreneurs, investors and policy-makers alike, as well as being avaluable information source for anyone interested in how high-tech businesses are created.
電子資源:	access to fulltext (Palgrave)

Venture capital and the European biotechnology industry[electronicresource] /
Bains, William,1955-

Venture capital and the European biotechnology industry[electronicresource] /William Bains. - Basingstoke [England] ;Palgrave Macmillan,2009. - 1 online resource (viii, 220 p.) :ill.

Description based on print version record.

Includes bibliographical references (p. 201-215) and indexes.

Introduction : the facts -- The biotechnology industry and venture capital -- Europe falls behind -- Why does Europe do so poorly? Some inadequate explanations -- Under-investment in European biotechnology -- Public markets and under-investment -- VC management of companies -- VC effects on business efficacy -- Investor blockade of business -- Pomp and circumstances -- The real VC business model -- What to do about it: government -- What to do about it: business -- References -- Index.

Why do so many European biotechnology companies fail? This book finds an answer in the behavior of the investors who dominate the industry and control the behavior of the companies they invest in. Starting froma detailed analysis of the history of the industry from its earliest days, this book cuts through the hype and mythology to identify what really happened to the biotechnology industryin Europe, what went wrong with the business, the management and the investment, and who are the controlling figures that made it happen. Bains uses real case studies anda wealth of statistical data to show how systematic under-investment and extraordinary business decisions have made European companies stunted mimics of their US counterparts. Building on an inside knowledge of how venture capital really works, he shows how this is not an accidentalside-product of European inexperience or lack of business acumen, but a necessary result of how venture capitalists run their businesses in Europe. This is an essential book for entrepreneurs, investors and policy-makers alike, as well as being avaluable information source for anyone interested in how high-tech businesses are created.

ISBN: 9780230227262 (electronic bk.)Subjects--Topical Terms:

377028
Biotechnology industries
--Finance.--EuropeIndex Terms--Genre/Form:

336502
Electronic books.

LC Class. No.: HD9999.B443 / E85125 2009eb

Dewey Class. No.: 660.6068/1

Venture capital and the European biotechnology industry[electronicresource] /
LDR:02930cam 2200301Ia 4500 001 328946
003 OCoLC
005 20100709081826.0
006 m d
007 cr cnu---unuuu
008 110607s2009 enka sb 001 0 eng d
020 $a 9780230227262 (electronic bk.)
020 $a 0230227260 (electronic bk.)
035 $a (OCoLC)319175573
035 $a ocn319175573
040 $a UKPGM $b eng $c UKPGM $d YDXCP $d N$T $d EBLCP $d CUS
043 $a e------
049 $a APTA
050 4 $a HD9999.B443 $b E85125 2009eb
082 0 4 $a 660.6068/1 $2 22
100 1 $a Bains, William, $d 1955- $3 377027
245 1 0 $a Venture capital and the European biotechnology industry $h [electronicresource] / $c William Bains.
260 $a Basingstoke [England] ; $a New York : $b Palgrave Macmillan, $c 2009.
300 $a 1 online resource (viii, 220 p.) : $b ill.
500 $a Description based on print version record.
504 $a Includes bibliographical references (p. 201-215) and indexes.
505 0 $a Introduction : the facts -- The biotechnology industry and venture capital -- Europe falls behind -- Why does Europe do so poorly? Some inadequate explanations -- Under-investment in European biotechnology -- Public markets and under-investment -- VC management of companies -- VC effects on business efficacy -- Investor blockade of business -- Pomp and circumstances -- The real VC business model -- What to do about it: government -- What to do about it: business -- References -- Index.
520 $a Why do so many European biotechnology companies fail? This book finds an answer in the behavior of the investors who dominate the industry and control the behavior of the companies they invest in. Starting froma detailed analysis of the history of the industry from its earliest days, this book cuts through the hype and mythology to identify what really happened to the biotechnology industryin Europe, what went wrong with the business, the management and the investment, and who are the controlling figures that made it happen. Bains uses real case studies anda wealth of statistical data to show how systematic under-investment and extraordinary business decisions have made European companies stunted mimics of their US counterparts. Building on an inside knowledge of how venture capital really works, he shows how this is not an accidentalside-product of European inexperience or lack of business acumen, but a necessary result of how venture capitalists run their businesses in Europe. This is an essential book for entrepreneurs, investors and policy-makers alike, as well as being avaluable information source for anyone interested in how high-tech businesses are created.
650 0 $a Biotechnology industries $z Europe $x Finance. $3 377028
650 0 $a Venture capital. $3 177527
655 7 $a Electronic books. $2 local $3 336502
776 0 8 $i Print version: $a Bains, William, 1955- $t Venture capital and the European biotechnology industry. $d Basingstoke [England] ; New York : Palgrave Macmillan, 2009 $z 9780230217195 $w (DLC) 2008029943 $w (OCoLC)234176084
856 4 0 $3 Palgrave Connect $u http://www.palgraveconnect.com/doifinder/10.1057/9780230227262 $z access to fulltext (Palgrave)